Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Description | Augmentin 250/62 SF oral suspension (GlaxoSmithKline UK Ltd) |
BNF code | 0501013K0BBAKAG |
Virtual Medicinal Product | Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free |
Name | Augmentin 250/62 SF oral suspension |
Date of name applicability | 9 Jan 2007 |
Previous name | Augmentin 250/62 S/F oral suspension |
Supplier | GlaxoSmithKline UK Ltd |
Current licensing authority | Medicines - MHRA/EMA |
EMA additional monitoring | ✗ |
Parallel import | ✗ |
Restrictions on availability | None |
Licensed Route | |
---|---|
Licenced route | Oral |
Actual Medicinal Product Packs | |
Augmentin 250/62 SF oral suspension (GlaxoSmithKline UK Ltd) 100 ml |
dm+d data retrieved from TRUD: release NHSBSA_5.2.0_20240520000001, imported on 20th May 2024 at 05:03:18.